- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Recent News
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction
Jun 15th, 2018
This study evaluated the effects of dulaglutide vs placebo on liver and glycaemic/metabolic measurements in a population with Type 2 diabetes and in a subgroup with non-alcoholic fatty liver/non-alcoholic steatohepatitis.Once-weekly […]
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
May 8th, 2018
Dendritic cell (DC) immunotherapy has been effective for prevention of type 1 diabetes (T1D) in NOD mice but fails to protect if initiated after active autoimmunity. As autoreactivity expands inter- and […]
Informational value of percent body fat with body mass index for the risk of abnormal blood glucose: a nationally representative cross-sectional study.
May 7th, 2018
To examine the value of percent body fat (%BF) with body mass index (BMI) to assess the risk of abnormal blood glucose (ABG) among US adults who are normal weight […]
ECHO Type 1 Diabetes
ECHO Type 1 Diabetes is an 18-month pilot program, which is allowing researchers at the University of Florida and Stanford University to learn more about how to improve care access for underserved adult and pediatric communities living with Type 1 Diabetes (T1D).